🇺🇸 FDA
Patent

US 10450364

Hyperimmunized egg product for treatment of necrotic enteritis in poultry

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 10450364 (Hyperimmunized egg product for treatment of necrotic enteritis in poultry) held by United States of America as represented by the Secretary of the Air Force expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K47/46, A61K9/0056